{"id":"https://openalex.org/W4282913414","doi":"https://doi.org/10.1158/1538-7445.am2022-ct128","title":"Abstract CT128: A study evaluating targeted therapies in participants who have advanced solid tumors with genomic alterations or protein expression patterns predictive of response (MyTACTIC)","display_name":"Abstract CT128: A study evaluating targeted therapies in participants who have advanced solid tumors with genomic alterations or protein expression patterns predictive of response (MyTACTIC)","publication_year":2022,"publication_date":"2022-06-15","ids":{"openalex":"https://openalex.org/W4282913414","doi":"https://doi.org/10.1158/1538-7445.am2022-ct128"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.am2022-ct128","doi":"https://doi.org/10.1158/1538-7445.am2022-ct128","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-ct128","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5018054038","display_name":"David Robert Spigel","orcid":"https://orcid.org/0000-0003-3215-9465","observed_orcids":["https://orcid.org/0000-0003-3215-9465"]},"institutions":[{"id":"https://openalex.org/I4210100810","display_name":"Sarah Cannon","ror":"https://ror.org/014t21j89","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210100810"]},{"id":"https://openalex.org/I4210135086","display_name":"Tennessee Oncology","ror":"https://ror.org/03754ky26","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210135086"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"David R. Spigel","raw_affiliation_strings":["1Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"1Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN;","institution_ids":["https://openalex.org/I4210100810","https://openalex.org/I4210135086"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009247512","display_name":"Zach Whitehead","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Zachary Whitehead","raw_affiliation_strings":["2Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5106557026","display_name":"Young Tae Kim","orcid":"https://orcid.org/0000-0001-9006-4881","observed_orcids":["https://orcid.org/0000-0001-9006-4881"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Young Kim","raw_affiliation_strings":["2Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053167365","display_name":"Tania Szado","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tania Szado","raw_affiliation_strings":["2Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Anne McDonald","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Anne McDonald","raw_affiliation_strings":["2Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057814118","display_name":"Walter C. Darbonne","orcid":"https://orcid.org/0000-0002-4386-1826","observed_orcids":["https://orcid.org/0000-0002-4386-1826"]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Walter C. Darbonne","raw_affiliation_strings":["2Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Jonathan Levy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I183934855","display_name":"Genentech","ror":"https://ror.org/04gndp242","country_code":"US","type":"company","lineage":["https://openalex.org/I118019719","https://openalex.org/I129302853","https://openalex.org/I183934855"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jonathan Levy","raw_affiliation_strings":["2Genentech, Inc., South San Francisco, CA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"2Genentech, Inc., South San Francisco, CA;","institution_ids":["https://openalex.org/I183934855"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5017277116","display_name":"Eucharia Borden","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210096410","display_name":"Cancer Support Community","ror":"https://ror.org/00tnycw03","country_code":"US","type":"nonprofit","lineage":["https://openalex.org/I4210096410"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Eucharia Borden","raw_affiliation_strings":["3Health Equity, Cancer Support Community, Philadelphia, PA;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"3Health Equity, Cancer Support Community, Philadelphia, PA;","institution_ids":["https://openalex.org/I4210096410"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101638085","display_name":"Daruka Mahadevan","orcid":"https://orcid.org/0000-0002-7129-5593","observed_orcids":["https://orcid.org/0000-0002-7129-5593"]},"institutions":[{"id":"https://openalex.org/I165951966","display_name":"The University of Texas at San Antonio Health Science Center","ror":"https://ror.org/02f6dcw23","country_code":"US","type":"education","lineage":["https://openalex.org/I165951966","https://openalex.org/I45438204"]},{"id":"https://openalex.org/I4390039360","display_name":"Mays Cancer Center at UT Health San Antonio","ror":"https://ror.org/04aysmc18","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I165951966","https://openalex.org/I4390039360","https://openalex.org/I45438204"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Daruka Mahadevan","raw_affiliation_strings":["4Mays Cancer Center, University of Texas Health, San Antonio, TX;"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"4Mays Cancer Center, University of Texas Health, San Antonio, TX;","institution_ids":["https://openalex.org/I165951966","https://openalex.org/I4390039360"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5038120683","display_name":"Ari M. Vanderwalde","orcid":"https://orcid.org/0000-0002-6842-2563","observed_orcids":["https://orcid.org/0000-0002-6842-2563"]},"institutions":[{"id":"https://openalex.org/I4210108188","display_name":"West Cancer Center","ror":"https://ror.org/01jkda844","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210108188"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ari VanderWalde","raw_affiliation_strings":["5West Cancer Center and Research Institute, Germantown, TN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"5West Cancer Center and Research Institute, Germantown, TN","institution_ids":["https://openalex.org/I4210108188"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":7,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":1,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":"82","issue":"12_Supplement","first_page":"CT128","last_page":"CT128"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.7085000276565552,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T11287","display_name":"Cancer Genomics and Diagnostics","score":0.7085000276565552,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10417","display_name":"Lung Cancer Treatments and Mutations","score":0.27880001068115234,"subfield":{"id":"https://openalex.org/subfields/2740","display_name":"Pulmonary and Respiratory Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0044999998062849045,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/targeted-therapy","display_name":"targeted therapy","score":0.7549999952316284},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8880000114440918},{"id":"https://openalex.org/keywords/metastatic-cancer","display_name":"metastatic cancer","score":0.8209999799728394},{"id":"https://openalex.org/keywords/basket-trials","display_name":"basket trials","score":0.6949999928474426},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7070000171661377},{"id":"https://openalex.org/keywords/genetic-alterations","display_name":"genetic alterations","score":0.7509999871253967},{"id":"https://openalex.org/keywords/ros1","display_name":"ROS1","score":0.7160000205039978},{"id":"https://openalex.org/keywords/pik3ca","display_name":"PIK3CA","score":0.972000002861023},{"id":"https://openalex.org/keywords/anaplastic-lymphoma-kinase","display_name":"anaplastic lymphoma kinase","score":0.9860000014305115},{"id":"https://openalex.org/keywords/akt","display_name":"Akt","score":0.9520000219345093},{"id":"https://openalex.org/keywords/pten","display_name":"PTEN","score":0.9980000257492065},{"id":"https://openalex.org/keywords/tumor-mutational-burden","display_name":"tumor mutational burden","score":0.9559999704360962},{"id":"https://openalex.org/keywords/microsatellite-instability","display_name":"microsatellite instability","score":0.9940000176429749},{"id":"https://openalex.org/keywords/mismatch-repair-deficiency","display_name":"mismatch repair deficiency","score":0.8529999852180481},{"id":"https://openalex.org/keywords/erbb2","display_name":"ERBB2","score":0.9850000143051147},{"id":"https://openalex.org/keywords/ret","display_name":"RET","score":0.9919999837875366},{"id":"https://openalex.org/keywords/immunotherapy","display_name":"immunotherapy","score":0.6980000138282776},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.5559999942779541},{"id":"https://openalex.org/keywords/objective-response-rate","display_name":"objective response rate","score":0.8619999885559082}],"concepts":[{"id":"https://openalex.org/C2777609662","wikidata":"https://www.wikidata.org/wiki/Q416356","display_name":"PTEN","level":4,"score":0.8027337789535522},{"id":"https://openalex.org/C117643217","wikidata":"https://www.wikidata.org/wiki/Q17824987","display_name":"Anaplastic lymphoma kinase","level":4,"score":0.6127781867980957},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6084141135215759},{"id":"https://openalex.org/C2779422266","wikidata":"https://www.wikidata.org/wiki/Q5186964","display_name":"Crizotinib","level":4,"score":0.6001043319702148},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5700008273124695},{"id":"https://openalex.org/C2781187634","wikidata":"https://www.wikidata.org/wiki/Q20969980","display_name":"KRAS","level":4,"score":0.5139722228050232},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4501134157180786},{"id":"https://openalex.org/C2781230642","wikidata":"https://www.wikidata.org/wiki/Q492646","display_name":"Targeted therapy","level":3,"score":0.4486449360847473},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.4485822021961212},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.44598498940467834},{"id":"https://openalex.org/C2908647359","wikidata":"https://www.wikidata.org/wiki/Q2625603","display_name":"Population","level":2,"score":0.44486668705940247},{"id":"https://openalex.org/C163763905","wikidata":"https://www.wikidata.org/wiki/Q17075943","display_name":"Precision medicine","level":2,"score":0.43659061193466187},{"id":"https://openalex.org/C32220436","wikidata":"https://www.wikidata.org/wiki/Q2072214","display_name":"Personalized medicine","level":2,"score":0.4242985248565674},{"id":"https://openalex.org/C2781197716","wikidata":"https://www.wikidata.org/wiki/Q864574","display_name":"Biomarker","level":2,"score":0.41511788964271545},{"id":"https://openalex.org/C2780265364","wikidata":"https://www.wikidata.org/wiki/Q5009957","display_name":"CDKN2A","level":3,"score":0.4144444763660431},{"id":"https://openalex.org/C2775999482","wikidata":"https://www.wikidata.org/wiki/Q18031208","display_name":"ROS1","level":4,"score":0.41017335653305054},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4017173945903778},{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.39574816823005676},{"id":"https://openalex.org/C60644358","wikidata":"https://www.wikidata.org/wiki/Q128570","display_name":"Bioinformatics","level":1,"score":0.38244909048080444},{"id":"https://openalex.org/C526805850","wikidata":"https://www.wikidata.org/wiki/Q188874","display_name":"Colorectal cancer","level":3,"score":0.24053096771240234},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.23947644233703613},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.2247474491596222},{"id":"https://openalex.org/C2781182431","wikidata":"https://www.wikidata.org/wiki/Q356033","display_name":"Adenocarcinoma","level":3,"score":0.19979164004325867},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.15135443210601807},{"id":"https://openalex.org/C2776256026","wikidata":"https://www.wikidata.org/wiki/Q47912","display_name":"Lung cancer","level":2,"score":0.14370596408843994},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.13901332020759583},{"id":"https://openalex.org/C2776232967","wikidata":"https://www.wikidata.org/wiki/Q6743514","display_name":"Malignant pleural effusion","level":3,"score":0.0},{"id":"https://openalex.org/C99454951","wikidata":"https://www.wikidata.org/wiki/Q932068","display_name":"Environmental health","level":1,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.am2022-ct128","doi":"https://doi.org/10.1158/1538-7445.am2022-ct128","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.am2022-ct128","pdf_url":null,"source":{"id":"https://openalex.org/S168522863","display_name":"Cancer Research","issn_l":"0008-5472","issn":["0008-5472","1538-7445"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320273","host_organization_name":"American Association for Cancer Research","host_organization_lineage":["https://openalex.org/P4310320273"],"host_organization_lineage_names":["American Association for Cancer Research"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Cancer Research","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3170670976","https://openalex.org/W4399667106","https://openalex.org/W3127293458","https://openalex.org/W4321480267","https://openalex.org/W2978467642","https://openalex.org/W4414614669","https://openalex.org/W2890863949","https://openalex.org/W3170111617","https://openalex.org/W2601744127","https://openalex.org/W2763259277"],"abstract_inverted_index":{"Abstract":[0],"Background:":[1],"Cancer":[2,440,451],"treatment":[3,277,300],"is":[4,144,321,383],"evolving":[5],"toward":[6],"a":[7,60,68,136,145,257],"more":[8,137],"personalized":[9],"approach":[10],"in":[11,80,172,281,414],"which":[12],"the":[13,35,50,282,331,366,436],"intersection":[14],"of":[15,27,71,96,256,260,298,350,429,435],"genomics,":[16],"pathology":[17],"and":[18,31,169,196,219,242,246,272,287,354,369],"imaging":[19],"methods":[20],"leads":[21],"to":[22,37,39,46,52,75,132,153,253,273,296,302,322,334,365,371,378],"individualized":[23],"care.":[24],"Furthermore,":[25],"identification":[26],"novel":[28],"genomic":[29,86,422],"alterations":[30,87,164,423],"other":[32],"biomarkers":[33,48,174],"has":[34,49,362],"potential":[36,51],"lead":[38],"customized,":[40],"targeted":[41,309,412],"treatments.":[42],"Matching":[43],"specific":[44,173],"therapies":[45,77,413],"tumor":[47,201],"yield":[53],"valuable":[54],"clinical":[55],"information.":[56],"Here":[57],"we":[58],"present":[59],"multiarm":[61],"basket":[62],"trial":[63],"that":[64,92,162,175],"matches":[65],"patients":[66,117,292,315],"with":[67,118,158,227,264,278,308,376,421],"broad":[69],"array":[70],"metastatic":[72],"solid":[73,160,419],"cancers":[74],"investigational":[76],"alone":[78],"or":[79,88,234,268,305,338,424],"combination":[81,306],"based":[82],"on":[83],"specific,":[84],"targetable":[85],"protein":[89,170,191,425],"expression":[90,426],"patterns":[91,427],"are":[93,290],"potentially":[94],"predictive":[95,428],"response":[97,326,430],"(MyTACTIC).":[98],"Historically,":[99],"such":[100],"trials":[101],"have":[102,250,417],"been":[103,251,363],"conducted":[104],"at":[105],"large":[106],"academic":[107,241],"medical":[108],"centers":[109,124,245],"rather":[110],"than":[111],"community":[112,123,243],"centers,":[113],"where":[114],"most":[115],"US":[116],"cancer":[119],"receive":[120,303],"treatment.":[121],"Prioritizing":[122],"for":[125,275,341,439],"this":[126],"study":[127,151,367,410],"presents":[128],"an":[129],"exciting":[130],"opportunity":[131],"generate":[133],"data":[134],"from":[135,232,240],"representative":[138],"patient":[139],"population.":[140],"Methods:":[141],"MyTACTIC":[142],"(NCT04632992)":[143],"phase":[146],"II,":[147],"multicenter,":[148],"nonrandomized,":[149],"open-label":[150],"aiming":[152],"enroll":[154],"approximately":[155],"260":[156],"participants":[157,415],"advanced":[159,418],"tumors":[161,420],"harbor":[163],"including":[165,262],"mutations,":[166],"fusions,":[167],"amplifications":[168],"loss":[171],"include":[176],"ROS":[177],"proto-oncogene":[178,221],"1":[179,297],"(ROS1),":[180],"phosphatidylinositol-4,5-Bisphosphate":[181],"3-Kinase":[182],"Catalytic":[183],"Subunit":[184],"Alpha":[185],"(PIK3CA),":[186],"anaplastic":[187],"lymphoma":[188],"kinase":[189,192,216],"(ALK),":[190],"B":[193],"(AKT),":[194],"phosphatase":[195],"tensin":[197],"homolog":[198],"(PTEN),":[199],"high":[200,205],"mutational":[202],"burden":[203],"(TMB),":[204],"microsatellite":[206],"instability":[207],"(MSI),":[208],"deficient":[209],"mismatch":[210],"repair":[211],"(dMMR),":[212],"erb-b2":[213],"receptor":[214],"tyrosine":[215],"2":[217],"(ERBB2)":[218],"Ret":[220],"(RET).":[222],"Patients":[223],"aged":[224],"\u226518":[225],"years":[226],"positive":[228],"local":[229],"biomarker":[230],"results":[231],"tissue":[233],"blood":[235],"samples":[236],"will":[237,293,356],"be":[238,294,358],"enrolled":[239],"oncology":[244],"practices.":[247],"Eligibility":[248],"criteria":[249,289,340],"broadened":[252],"allow":[254,274],"enrollment":[255],"diverse":[258],"population":[259],"patients,":[261],"those":[263],"nonmeasurable":[265],"disease,":[266],"HIV":[267],"viral":[269],"hepatitis":[270],"infections,":[271],"previous":[276],"anticancer":[279],"agents":[280],"same":[283],"class.":[284],"Once":[285],"general":[286],"arm-specific":[288],"met,":[291],"assigned":[295],"15":[299],"arms":[301],"mono-":[304],"therapy":[307],"agents,":[310],"immunotherapy":[311],"and/or":[312],"chemotherapy":[313],"(\u226425":[314],"per":[316],"arm).":[317],"The":[318],"primary":[319,342],"objective":[320,325],"evaluate":[323],"confirmed":[324],"rate,":[327],"as":[328],"assessed":[329],"by":[330],"investigator":[332],"according":[333],"RECIST":[335],"version":[336],"1.1":[337],"RANO":[339],"central":[343],"nervous":[344],"system":[345],"tumors.":[346],"Progression-free":[347],"survival,":[348],"duration":[349],"response,":[351],"overall":[352],"survival":[353],"safety":[355],"also":[357],"assessed.":[359],"Special":[360],"attention":[361],"paid":[364],"design":[368],"implementation":[370],"ensure":[372],"equitable":[373],"access,":[374],"along":[375],"flexibility":[377],"add":[379],"additional":[380],"baskets.":[381],"Enrollment":[382],"ongoing.":[384],"Citation":[385],"Format:":[386],"David":[387],"R.":[388],"Spigel,":[389],"Zachary":[390],"Whitehead,":[391],"Young":[392],"Kim,":[393],"Tania":[394],"Szado,":[395],"Anne":[396],"McDonald,":[397],"Walter":[398],"C.":[399],"Darbonne,":[400],"Jonathan":[401],"Levy,":[402],"Eucharia":[403],"Borden,":[404],"Daruka":[405],"Mahadevan,":[406],"Ari":[407],"VanderWalde.":[408],"A":[409],"evaluating":[411],"who":[416],"(MyTACTIC)":[431],"[abstract].":[432],"In:":[433],"Proceedings":[434],"American":[437],"Association":[438],"Research":[441],"Annual":[442],"Meeting":[443],"2022;":[444],"2022":[445],"Apr":[446],"8-13.":[447],"Philadelphia":[448],"(PA):":[449],"AACR;":[450],"Res":[452],"2022;82(12_Suppl):Abstract":[453],"nr":[454],"CT128.":[455]},"counts_by_year":[{"year":2025,"cited_by_count":1}],"updated_date":"2026-10-27T15:51:10.671819","created_date":"2022-06-16T00:00:00"}